ArticleFEBS open bio2021

Inhibition of galectin-3 augments the antitumor efficacy of PD-L1 blockade in non-small-cell lung cancer.

Hongxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.